Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models

Authors

Amy J. Wegener, Washington University School of Medicine in St. Louis
Amy Setnicka, Washington University School of Medicine in St. Louis
Kathleen M. Schoch, Washington University School of Medicine in St. Louis
Mariah L. Hoye, Washington University School of Medicine in St. Louis
Mark Shabsovich, Washington University School of Medicine in St. Louis
Timothy M. Miller, Washington University School of Medicine in St. Louis
et al

Journal

The Journal of Clinical Investigation

Publication Date

2018

Volume

128

Issue

8

Inclusive Pages

3558-3567

Document Type

Open Access Publication

DOI

10.1172/JCI99081

Rights and Permissions

Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. Alex McCampbell, … , Eric E. Swayze, Timothy M. Miller. J Clin Invest. 2018; 128(8):3558-3567. https://doi.org/10.1172/JCI99081.

Recommended Citation

Wegener, Amy J.; Setnicka, Amy; Schoch, Kathleen M.; Hoye, Mariah L.; Shabsovich, Mark; Miller, Timothy M.; and et al, "Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models." The Journal of Clinical Investigation. 128, 8. 3558-3567. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/6981